Lixte Biotechnology Holdings, Inc. LIXT 深 沪
等待开盘 05-19 09:30:00 美东时间
4.70
-0.460
-8.91%
华盛通- 最 高5.2699
- 今 开5.14
- 成交量 6.74万股
- 最 低 4.65
- 昨 收 5.16
- 总市值 5819.98万
- 52周最高 6.26
- 市盈率 静 --
- 换手率 0.54%
- 52周最低 0.64
- 委 比 -97.08%
- 总股本 1238.29万
- 历史最高 71.90
- 量 比 0.81
- 振 幅 12.01%
- 历史最低 0.64
- 每 手 1
- 风险率 1.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lixte Biotech Hldgs Q1 EPS $(0.18) Up From $(0.29) YoY
Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.18) per share. This is a 37.93 percent increase over losses of $(0.29) per share from the same period last year.
05-15 05:17
Lixte Biotech Hldgs Q4 EPS $(0.34) Down From $(0.27) YoY
Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.34) per share. This is a 25.93 percent decrease over losses of $(0.27) per share from the same period last year.
04-01 06:52
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline
Austin, Texas, United States, March 10th, 2026, FinanceWire LIXTE Biotechnology...
03-11 00:00
LIXTE Announces An Expansion Of Its Collaboration With The University Of Texas MD Anderson Cancer Center And Pharmaceutical Manufacturer GSK On An Ongoing Clinical Trial Evaluating Its Proprietary Compound LB-100 In Combination With GSK's Dostarlimab For The Treatment Of Ovarian Clear Cell Cancer
LIXTE Biotechnology Holdings (NASDAQ:LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial
01-09 05:02
Lixte Biotechnology Enters Share Exchange Agreement, Swapping 2,700 Series C Preferred Shares For 700,000 Common Shares And ~20% Of Outstanding Shares For Subsidiary Liora Technologies Europe
On December 30, 2025, Lixte Biotechnology Holdings, Inc., a Delaware corporation (the "Company"), entered into a Share Exchange Agreement (the "Agreement") with Orbit Capital Inc., a Cayman Islands corporation
01-01 05:05
Lixte Biotechnology Announces New Registered Direct Offering
Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On Decembe...
2025-12-23 06:48
Lixte Biotechnology Holdings shares are trading lower after the company announced it commenced a $4.3 million common stock offering at $4.09 per common unit.
Lixte Biotechnology Holdings shares are trading lower after the company announc...
2025-12-18 22:26
Lixte Biotechnology Commences $4.3M Common Stock, Pre-Funded Offering At $4.09/Common Unit
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the "Company"), a biotech company focused on advancing cancer treatments, today announced that it has entered into definitive agreements in a registered direct offering
2025-12-18 22:11
Lixte Biotechnology Holds Annual Meeting, Approves Key Issues
The latest update is out from Lixte Biotechnology Holdings ( ($LIXT) ). On Dece...
2025-12-12 04:17
LIXTE Biotechnology Acquires Liora Technologies Europe
LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT) a biotech company focused on advancing cancer treatments, today announced it has completed the acquisition of Liora Technologies Europe Ltd., a
2025-11-25 21:33
